Sustainability Report

Overview

The report describes Pharmesis International Ltd.'s FY2020 sustainability activities, including a GRI-based materiality assessment that prioritized Economic Performance, Product Quality and Safety, and Occupational Health and Safety. Group total revenue was RMB 47.1 million, while loss before tax was RMB 5.8 million. The report states that zero workplace injuries were achieved during FY2020 and includes a GRI content index.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services